Spinal cord neoplasms - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Disease Reportsspinal cord neoplasms

MeSH D013120 - spinal cord neoplasms

Favorite

Competitive Landscape

Events Timeline

Commercial

Clinical Trials

Competitive landscape

D016543:Central nervous system neoplasms

$

Success rate

D013118:Spinal cord diseases

0 Companies

0 Drugs

Success rate

Spinal cord neoplasms

$

Success rate

D015174:Epidural neoplasms

0 Companies

0 Drugs

Success rate

Events Timeline

Commercial

No Data

Clinical Trials

Historical Success Rate

Phase 1

20%

1/5

Phase 2

63%

5/8

Phase 3

17%

1/6

Approved: 1Overall Success rate: 2%

All Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Company name

Phase 1

Phase 2

Phase 3

Phase 4

Drug Name

Impax Laboratories

1

2

>

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use